Skip to content

    Breast Cancer Health Center

    Font Size

    Diabetes Drug Fights Breast Cancer

    Metformin Kills Breast Cancer Stem Cells, May Fight Many Cancers
    WebMD Health News
    Reviewed by Louise Chang, MD

    Sept. 14, 2009 - The next breakthrough breast cancer treatment may be a diabetes drug already on the shelves of nearly every pharmacy.

    The drug is metformin, available generically and under brand names such as Glucophage and Fortamet. A growing body of evidence suggests that diabetes patients taking metformin are less likely to get cancer, and have better outcomes if they do get cancer, than those not taking the drug.

    Now Harvard researcher Kevin Struhl, PhD, and colleagues find that metformin can kill breast cancer stem cells, thought to be the cells responsible for breast cancer spread and recurrence.

    And in mice carrying human breast cancers, metformin made standard chemotherapy vastly more effective. Mice treated with the combination remain cancer-free for four months, unlike mice treated with either drug alone.

    "We have discovered new properties of metformin that can be of some use in cancer treatment and even prevention," Struhl said at a news conference held to announce the findings.

    While his current study looked at metformin's effects on breast cancer, Struhl says the drug may affect other types of cancer as well.

    "Although our studies were pretty much done on breast cancer cells, a lot of the principles are not specific just to breast cancer," Struhl said. "A lot of data shows lower cancer risk -- not just breast cancer -- in people taking metformin for diabetes."

    Metformin Kills Cancer Stem Cells

    What's so special about yet another drug that kills cancer cells in mice?

    For one thing, the kind of cancer cells metformin targets are cancer stem cells, which are resistant to standard chemotherapy.

    "This is the first time it's been shown that metformin may have an effect on these very resistant cancer cells. It is very exciting research," Dana-Farber Cancer Institute researcher Jennifer A Ligibel, MD, said at the news conference.

    The very existence of cancer stem cells has been debated. That debate is now "water under the bridge," Frank Rauscher, PhD, suggested at the news conference. Rauscher, a cancer researcher at the Wistar Institute, is editor-in-chief of Cancer Research, which published the Struhl study in today's advance online edition.

    Today on WebMD

    Breast Cancer Overview
    From mammograms to living after treatment.
    Dealing with breast cancer
    Get answers to your questions.
    woman having mammogram
    The 3 latest tips to know.
    woman undergoing breast cancer test
    Most abnormalities aren’t breast cancer.
    Resolved To Quit Smoking
    Breast Cancer Treatments Improving
    Woman getting mammogram
    Screening Tests for Women
    serious woman
    Pink badge on woman chest to support breat cancer
    what is your cancer risk
    breast cancer survivors